1-3 of 3
Thomas Chung
Close
Sort by
Journal Articles

Interim Analysis of the Extension Study with rVIII-SingleChain in Previously Untreated Patients (PUPs) with Severe Hemophilia A (CSL627-3001)

Elena Santagostino, Kathelijn Fischer, Christoph Koenigs, MD PhD, Claudia Djambas Khayat, MD BSc, Samantha Lucas, Blanca Salazar, Andres Brainsky, MD, Thomas Chung, Brahm Goldstein, Johnny Mahlangu, MMed, FCPath
Journal: Blood
Blood (2019) 134 (Supplement_1): 162.
https://doi.org/10.1182/blood-2019-123981
Published: 2019
Journal Articles

Chemical Biology Strategy Reveals Cell Lineage- and Cell Differentiation-Specific Small Molecule Inhibitors of NF-κB.

Hideki Goto, MD, PhD, Paul Diaz, PhD, Shu-ichi Matsuzawa, PhD, Eduard Sergienko, PhD, Steve Vasile, PhD, Thomas Chung, PhD, Carina Wimer, Michael Hedrick, PhD, Ricardo Correa, PhD, Thomas J Kipps, MD, PhD, Anthony Pinkerton, PhD, John C. Reed, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 2421.
https://doi.org/10.1182/blood.V120.21.2421.2421
Published: 2012
Journal Articles

Discovery and Characterization of Chemical Inhibitors of UBC13.

Charitha Madiraju, PhD, Shu-ichi Matsuzawa, PhD, Robert Ardecky, PhD, Ian Pass, PhD, Tram Ngo, Yasuko Matsuzawa, Carina Wimer, Michael Cuddy, Paul Diaz, PhD, Correa Ricardo, PhD, Craig Tamble, PhD, Chih-Wen Shu, PhD, Anthony Pinkerton, PhD, Eduard Sergienko, PhD, Chris Hassig, PhD, Thomas Chung, PhD, John C. Reed, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 2950.
https://doi.org/10.1182/blood.V120.21.2950.2950
Published: 2012